NSE filing, NSE: FORTIS. Summary written from the filing by ALFA Finder's alert engine.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹759.50
- Market cap
- ₹57,339 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 54.7×Sector 52.0×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 23.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Fortis Healthcare Acquisition Worth ₹277 Cr
Fortis Healthcare's wholly-owned subsidiary IHL acquired Suguna Hospital's business and land in Bengaluru via slump sale. The cumulative consideration is approximately INR 277 Crore, consummated today.
- Value
- ₹277.0 Cr
Fortis Healthcare Other Announcement
Fortis Healthcare Ltd filed its quarterly shareholding pattern for the quarter ended 30th September 2026 as per SEBI regulatory requirements.
Fortis Healthcare Acquisition Worth ₹1.85 Cr
Fortis Hospotel will acquire 26% of Clean Max Sau Pvt Ltd for ₹1.85 Crore. The SPV develops a captive solar project in Haryana for energy cost optimization.
- Value
- ₹1.85 Cr
- Execution
- Within 3 months of execution of the agreement
Fortis Healthcare Capacity Expansion: ₹1.85 Cr Investment
Subsidiary acquired 26% of an SPV for a captive solar project in Haryana. Investment of up to Rs. 1.85 Crore meets the company's green energy needs.
- Value
- ₹1.85 Cr
- Execution
- Within 3 months of execution of the agreement
Fortis Healthcare Debt & Borrowing
Fortis Healthcare files its half-yearly statement of listed debt securities as on September 30, 2026. Three NCD tranches maturing December 2029 remain outstanding with floating coupon rates.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.